Cargando…

Comparison of epidermal growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) immunohistochemical expression and outcomes in canine nasal carcinomas treated with radiation therapy

The expression of epidermal growth factor receptor (EGFR) and cyclooxygenase-2 (COX-2) has been reported in human nasopharyngeal and canine nasal carcinomas. The present study measured EGFR and COX-2 expression and calculated correlations between these proteins and clinical variables and outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales:	FU, Dah-Renn, KADOSAWA, Tsuyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Veterinary Science 2022
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523303/ https://www.ncbi.nlm.nih.gov/pubmed/35851267 http://dx.doi.org/10.1292/jvms.22-0106

Ejemplares similares

Prognostic Utility of Apoptosis Index, Ki-67 and Survivin Expression in Dogs with Nasal Carcinoma Treated with Orthovoltage Radiation Therapy
por: FU, Dah-Renn, et al.
Publicado: (2014)

Apoptosis and Ki-67 as predictive factors for response to radiation therapy in feline nasal lymphomas
por: FU, Dah-Renn, et al.
Publicado: (2016)

Epidermal growth factor receptor expression in canine transitional cell carcinoma
por: HANAZONO, Kiwamu, et al.
Publicado: (2014)

Colorectal Carcinoma, Cyclooxygenases, and COX Inhibitors
por: Ganduri, Vinutna, et al.
Publicado: (2022)

Cyclooxygenase-2 (COX-2) Expression in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma: An Immunohistochemical Study
por: Aparnadevi, Potsangbam, et al.
Publicado: (2022)

Expression of cyclooxygenase-2 (COX-2) in pituitary tumours
por: Sokołowski, Grzegorz, et al.
Publicado: (2012)

First study on the immunohistochemical expression of cyclooxygenase-2 and clinicopathological association in canine hepatoid gland neoplasms
por: Chantawong, Pinkarn, et al.
Publicado: (2022)

Immunohistochemical detection of a potential molecular therapeutic target for canine hemangiosarcoma
por: ADACHI, Mami, et al.
Publicado: (2015)

Endometritis in the bitch: Immunohistochemical localization of cyclooxygenase 2
por: Mitacek, María Carla García, et al.
Publicado: (2020)

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney
por: Smith, Francine G., et al.
Publicado: (2012)

Cyclooxygenase-2 immunohistochemical expression in serrated polyps of the colon
por: Kiedrowski, Miroslaw, et al.
Publicado: (2014)

Pancreatic Stellate Cells (PSCs) express Cyclooxygenase-2 (COX-2) and pancreatic cancer stimulates COX-2 in PSCs
por: Yoshida, Seiya, et al.
Publicado: (2005)

Immunohistochemical Expression of COX-2 in Thyroid Nodules
por: Kim, Sang Jin, et al.
Publicado: (2003)

Cox-2: Where are we in 2003? - The role of cyclooxygenase-2 in bone repair
por: Einhorn, Thomas A
Publicado: (2003)

Reduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2012)

Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management
por: Rawat, Chitra, et al.
Publicado: (2019)

Bioactivity of dihydropyrimidinone derivatives as inhibitors of cyclooxygenase-2 (COX-2): an in silico approach
por: Haq, Kautsar Ul, et al.
Publicado: (2023)

Nucleobindin Co-Localizes and Associates with Cyclooxygenase (COX)-2 in Human Neutrophils
por: Leclerc, Patrick, et al.
Publicado: (2008)

Prognostic significance of midline shift of the olfactory or frontal lobes of the brain in canine nasal carcinomas treated by palliative radiotherapy: a pilot study
por: WADA, Yusuke, et al.
Publicado: (2018)

Significance of CYCLOOXYGENASE-2(COX-2), PERIOSTIN (POSTN) and INTERLEUKIN-4(IL-4) gene expression in the pathogenesis of chronic rhinosinusitis with nasal polyps
por: Miłoński, Jarosław, et al.
Publicado: (2015)

The potential role of COX-2 in cancer stem cell-mediated canine mammary tumor initiation: an immunohistochemical study
por: Huang, Jian, et al.
Publicado: (2015)

Histological and immunohistochemical evaluation of stroma variations and their correlation with the Ki-67 index and expressions of glucose transporter 1 and monocarboxylate transporter 1 in canine thyroid C-cell carcinomas
por: KAWAMURA, Yoshio, et al.
Publicado: (2016)

Intrapancreatic accessory spleen mimicking pancreatic insulinoma with intrapancreatic metastasis in a cat
por: TOMURA, Shintaro, et al.
Publicado: (2022)

A Systematic Review of the Cyclooxygenase-2 (COX-2) Expression in Rectal Cancer Patients Treated with Preoperative Radiotherapy or Radiochemotherapy
por: Berbecka, Monika, et al.
Publicado: (2021)

Cyclooxygenase in normal human tissues – is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?
por: Zidar, Nina, et al.
Publicado: (2009)

Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors
por: Harris, Randall E, et al.
Publicado: (2006)

Regional Differences in the Neuronal Expression of Cyclooxygenase-2 (COX-2) in the Newborn Pig Brain
por: Oláh, Orsolya, et al.
Publicado: (2012)

Reversible Suppression of Cyclooxygenase 2 (COX-2) Expression In Vivo by Inducible RNA Interference
por: Zaiss, Anne K., et al.
Publicado: (2014)

Transgenic expression of cyclooxygenase-2 (COX2) causes premature aging phenotypes in mice
por: Kim, Joohwee, et al.
Publicado: (2016)

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
por: Sethi, Rickinder, et al.
Publicado: (2019)

The Search for Cyclooxygenase-2 (COX-2) Inhibitors for the Treatment of Inflammation Disease: An in-silico Study
por: Ruslin, Ruslin, et al.
Publicado: (2022)

Expression of cyclooxygenase 2 in oral submucous fibrosis: An immunohistochemical pilot study
por: Rangaswamy, Shruthi, et al.
Publicado: (2019)

Binding Energy Calculation of Patchouli Alcohol Isomer Cyclooxygenase Complexes Suggested as COX-1/COX-2 Selective Inhibitor
por: Raharjo, Sentot Joko, et al.
Publicado: (2014)

Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer
por: Cox, D G, et al.
Publicado: (2004)

Immunohistochemical Expression of Cyclooxygenases in Hypertrophic Scars and Keloids
por: Pavelecini, Michel, et al.
Publicado: (2019)

Allelic variation in the canine Cox-2 promoter causes hypermethylation of the canine Cox-2 promoter in clinical cases of renal dysplasia
por: Whiteley, Mary H
Publicado: (2014)

Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications
por: Ferrandina, G, et al.
Publicado: (2002)

Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus
por: Bhandari, Pradeep, et al.
Publicado: (2006)

PET imaging of cyclooxygenase-2 (COX-2) in a pre-clinical colorectal cancer model
por: Tietz, Ole, et al.
Publicado: (2016)

Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
por: Westwell-Roper, Clara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p0gmhvq161vi70ljh31qaoiq00